RxDoctor Payments Data

Maxwell Sapolsky, PA

Physician Assistant · Middleburg, FLNPI 1487027371

Payments from drug & device makers

$428in general payments, 2019–2025

Across 18 payments — averaging $23.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$164
  • Johnson & Johnson$123
  • Stryker$37
  • Novartis$36
  • Boston Scientific$22
  • Lantheus Medical Imaging, Inc.$20
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$428100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$428 in reported general payments places this provider in the 45th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$65,907
Medicare patients
409
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban156$186,235
EntrestoSacubitril/Valsartan103$179,004
Repatha SureclickEvolocumab74$80,422
JardianceEmpagliflozin38$59,911
FarxigaDapagliflozin Propanediol32$38,060
BrilintaTicagrelor36$31,754
XareltoRivaroxaban19$29,417
Repatha SyringeEvolocumab13$7,153
Atorvastatin Calcium402$4,201
ClopidogrelClopidogrel Bisulfate374$4,148
Metoprolol Succinate304$3,471
Ezetimibe219$3,177
Rosuvastatin Calcium187$2,457
Carvedilol249$2,253
Ranolazine ErRanolazine18$1,896

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$36$179,004103 claims
AstraZenecaFarxiga, Brilinta$14$69,81468 claims
Johnson & JohnsonXarelto$123$29,41719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Middleburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →